Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Therapy Versus High Flow Nasal Cannula Oxygen Therapy Alone in Patients With de Novo Acute Hypoxemic Respiratory Failure: a Prospective, Randomized Controlled Trial. [NA]

View source ↗

Summary

This clinical trial update notes a randomized comparison of CPAP plus high-flow nasal cannula versus high-flow nasal cannula alone for de novo acute hypoxemic r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Continuous Positive Airway Pressure (CPAP)
  • High Flow Nasal Cannula Oxygen Therapy (High-flow nasal cannula)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: De Novo Hypoxemic Acute Respiratory Failure (hARF) | NA | Status: RECRUITING